NeuroPace, Inc. (NPCE) vs Shoulder Innovations, Inc. (SI)
- NeuroPace, Inc. NPCE 12.24 −4.23%
- Shoulder Innovations, Inc. SI 18.09 −1.52%
NeuroPace, Inc. and Shoulder Innovations, Inc. are both Medical Devices companies. NeuroPace, Inc. is the larger, with a market value of $438.7M against $382.4M — 1.1× the size. Shoulder Innovations, Inc. grew revenue faster over the last twelve months: 62.9% against 21.7%. NeuroPace, Inc. has the higher net margin (−18.6% vs −58.3%) and the higher return on invested capital (−44.6% vs −54.7%). Across the 17 metrics below, NeuroPace, Inc. leads on 12 and Shoulder Innovations, Inc. on 5.
Valuation
Profitability
| Metric | NPCE | SI | Medical Devices median |
|---|---|---|---|
| Gross margin | 78.38% | 77.34% | 56.01% |
| Operating margin | (13.33%) | (58.53%) | (15.03%) |
| Net margin | (18.58%) | (58.33%) | (20.40%) |
| Free cash flow margin | (11.29%) | (78.39%) | (7.24%) |
| Return on equity | (122.05%) | (151.89%) | (15.32%) |
| Return on assets | (18.82%) | (30.49%) | (19.72%) |
| Return on invested capital | (44.64%) | (54.72%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack